00469-1425 Xospata - CanMED: NDC

Product NDC:

00469-1425

Brand Name:

Xospata

Generic Name:

Gilteritinib

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: GILTERITINIB FUMARATE

Strength: 40.0

Unit: mg/1

Packages:

Code: 00469-1425-21

Description: 1 BOTTLE in 1 CARTON (0469-1425-21) / 21 TABLET in 1 BOTTLE

Effective Date: April 30, 2022

Discontinued:

Code: 00469-1425-90

Description: 1 BOTTLE in 1 CARTON (0469-1425-90) / 90 TABLET in 1 BOTTLE

Effective Date: Nov. 29, 2018

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

FLT3

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox